RecruitingNot Applicable

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

Denmark1,000 participantsStarted 2021-09-01

Plain-language summary

In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients 18 years or older with a diagnosis of psoriasis will be invited to participate Exclusion Criteria: * Patients not able to cooperate to the study * Patients unable understand and sign informed consent

What they're measuring

Cardiovascular mortality

Timeframe: 2 year follow-up

Cardiovascular mortality

Timeframe: 5 year follow-up

Cardiovascular mortality

Timeframe: 10 year follow-up

Myocardial infarction

Timeframe: 2 year follow up

Myocardial infarction

Timeframe: 5 year follow up

Myocardial infarction

Timeframe: 10 year follow up

Coronary revascularization

Timeframe: 2 year follow up

Coronary revascularization

Timeframe: 5 year follow up

Coronary revascularization

Timeframe: 10 year follow up

Trial details

NCT IDNCT04950218

SponsorHerlev and Gentofte Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2034-10-01

Contact for this trial

Maria F Dons, MD

+4560604780 mariaflarupdons@hotmail.com

View on ClinicalTrials.gov More Psoriasis trials